01—Abstract
Summary
Summary of the 10-K filed March 8, 2005. Cited figures are marked; the original filing is the authoritative source.
Tenet Healthcare Corporation reported a net loss of $2.64 billiona for the year ended December 31, 2004, compared with a net loss of $1.48 billion for 2003, and a loss from continuing operations of $1.80 billion (diluted loss of $(3.85) per share).
Net operating revenues were $9.92 billionb in 2004 versus $10.15 billion in 2003. The loss was driven by $1.27 billion of impairment and restructuring charges (including a $1.11 billion goodwill impairment), a $480 million valuation allowance recorded against deferred tax assets in continuing operations, $74 million of litigation and investigation costs, and a $395 million Redding Medical Center patient litigation settlement reported within discontinued operations. Volumes declined: outpatient visits fell 4.3% and admissions fell 1.4% at continuing general hospitals, and provision for doubtful accounts rose to $1.21 billion, or 12.2% of net operating revenues.
The company is restructuring around 69 general hospitals after announcing in January 2004 the divestiture of 27 hospitals; as of December 31, 2004 it had completed 18 of those divestitures and signed a definitive agreement for four more. Liquidity was supported by $654 millionc of unrestricted cash, a $773 million net proceeds senior notes offering in January 2005, and an expected $530 million income tax refund in 2005, though operating cash flow was negative $82 million for 2004.
The filing states management does not anticipate significant improvement in operating performance in 2005, and it describes extensive government investigations, qui tam actions, and class actions over pricing and Medicare outlier payments, including a Florida AG and Boca Raton RICO suit filed in March 2005. Shareholders' equity fell to $1.73 billiond at year-end 2004 from $4.36 billion a year earlier, and the company has not paid cash dividends on common stock since fiscal 1994 and does not intend to pay them in the foreseeable future.
02—Key points
Key Highlights
- Net loss of $2.64 billion for 2004 versus $1.48 billion in 2003; diluted loss per share from continuing operations of $(3.85).
- Net operating revenues of $9.92 billion in 2004, down from $10.15 billion in 2003; outpatient visits decreased 4.3% and admissions decreased 1.4%.
- Impairment and restructuring charges of $1.27 billion in 2004, including a $1.11 billion goodwill impairment, plus a $480 million valuation allowance on deferred tax assets in continuing operations.
- Provision for doubtful accounts of $1.21 billion (12.2% of net operating revenues), reflecting growth in uninsured and underinsured patients; the Compact with Uninsured Patients recorded $277 million in self-pay discounts.
- Restructuring to 69 general hospitals: 18 of 27 planned divestitures completed by December 31, 2004, with a definitive agreement for four more.
- Liquidity: $654 million unrestricted cash at year-end; $800 million senior notes sold in January 2005 (approximately $773 million net proceeds); expected 2005 income tax refunds of about $530 million; operating cash flow was negative $82 million in 2004.
- Extensive legal exposure: $395 million Redding Medical Center patient settlement, pending federal investigations, securities and derivative litigation, and a March 2005 Florida AG RICO suit; shareholders' equity declined to $1.73 billion.
03—Questions
Frequently Asked Questions
Why did Tenet post such a large loss in 2004?
The loss reflects $1.27 billion of impairment and restructuring charges, mainly a $1.11 billion goodwill impairment for the Texas-Gulf Coast and Florida-Alabama regions; a $480 million valuation allowance on deferred tax assets in continuing operations; a $395 million Redding Medical Center litigation settlement in discontinued operations; higher provisions for doubtful accounts; and declining volumes.
What is the company's plan to return to profitability?
The company is focusing on 69 general hospitals after proposed divestitures, consolidating its operating regions from five to four, reducing costs, and pursuing clinical quality initiatives under its Commitment to Quality program. However, management stated it does not anticipate significant improvement in operating performance in 2005.
How is Tenet funding its operations and debt obligations?
At year-end 2004 the company had $654 million of unrestricted cash. It issued $1 billion of 9 7/8% senior notes in June 2004, sold $800 million of 9 1/4% senior notes in January 2005, and replaced its five-year credit agreement with a one-year $250 million letter of credit facility. It expects approximately $530 million in income tax refunds in 2005 and said its remaining significant long-term debt is not due until December 2011.
What are the main legal and regulatory risks disclosed?
The filing describes government investigations into physician relationships, Medicare outlier payments, and coding practices; a federal False Claims Act suit over Medicare coding; class actions over uninsured patient pricing in multiple states; securities class and derivative litigation; an SEC formal investigation; an IRS proposed deficiency of $157 million plus interest; and a March 2005 RICO suit by the Florida Attorney General and others. The company states it cannot predict the ultimate outcome.
04—Continue